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Abstract TBC1D4 (or AS160) was identified as a Rab-
GTPase activating protein (Rab-GAP) that controls insulin-
dependent trafficking of the glucose transporter GLUT4 in
skeletal muscle cells and in adipocytes. Recent in vitro cell
culture studies suggest that TBC1D4 may also regulate the
intracellular trafficking of kidney proteins such as the
vasopressin-dependent water channel AQP2, the aldoste-
rone-regulated epithelial sodium channel ENaC, and the
Na?-K?-ATPase. To study the possible role of TBC1D4 in
the kidney in vivo, we raised a rabbit polyclonal antibody
against TBC1D4 to be used for immunoblotting and
immunohistochemical studies. In immunoblots on mouse
kidney homogenates, the antibody recognizes specific
bands at the expected size of 160 kDa and at lower
molecular weights, which are absent in kidneys of
TBC1D4 deficient mice. Using a variety of nephron-seg-
ment-specific marker proteins, immunohistochemistry
reveals TBC1D4 in the cytoplasm of the parietal epithelial
cells of Bowman’s capsule, the thin and thick limbs of
Henle’s loop, the distal convoluted tubule, the connecting
tubule, and the collecting duct. In the latter, both principal
as well as intercalated cells are TBC1D4-positive. Thus,
with the exception of the proximal tubule, TBC1D4 is
highly expressed along the nephron and the collecting duct,
where it may interfere with the intracellular trafficking of
many renal transport proteins including AQP2, ENaC and
Na?-K?-ATPase. Hence, TBC1D4 may play an important
role for the control of renal ion and water handling and
hence for the control of extracellular fluid homeostasis.
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Introduction
The kidney plays an important role for whole-body
homeostasis by regulated filtration, excretion and reab-
sorption of water, solutes and electrolytes along the
nephron. These transport processes are largely coupled to
the activity of transport proteins and channels in the apical
and basolateral plasma membrane of the epithelial cells
lining the tubular lumen. In recent years, most of these
transport proteins have been identified, which allowed to
study their regulation at the molecular level. Interestingly,
the activity of many of these proteins is regulated, at least
in part, by changes in their cell surface abundance. For
example, in the proximal tubule (PT), rapid endocytosis of
the NaPi-IIa-cotransporter regulates phosphate reabsorp-
tion in response to parathyroid hormone (PTH) or increased
dietary phosphate intake (Murer et al. 2003). Likewise,
altered cell surface abundances of the bumetanide-sensitive
NaK2Cl cotransporter (NKCC2) and of the thiazide-sen-
sitive NaCl cotransporter (NCC) contribute to the vaso-
pressin- and angiotensin II-dependent control of sodium
reabsorption in the thick ascending limb (TAL) and the
distal convoluted tubule (DCT), respectively (Mount 2006;
Mutig et al. 2010; Sandberg et al. 2007). In the downstream
localized connecting tubule (CNT) and collecting duct
(CD), the vasopressin- and aldosterone-dependent stimu-
lation of water and sodium reabsorption relies on the rapid
translocation of aquaporin-2 (AQP2) water channels and
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amiloride-sensitive epithelial sodium channels (ENaC)
from intracellular storage sites to the luminal membrane
(Loffing and Korbmacher 2009; Nielsen et al. 2002). Also,
the electrogenic hydrogen pump (H?-ATPase) in the
intercalated cells (IC) of cortical and medullary collecting
ducts is regulated by rapid insertion in, or removal from,
the plasma membrane in response to an altered acid–base
status (Wagner et al. 2004). Finally, the basolateral sodium
pump (Na?-K?-ATPase) can reside in latent intracellular
compartments, from where it is translocated to its pre-
dominant localization at the basolateral plasma membrane
(Feraille and Doucet 2001). Thus, regulated trafficking of
membrane proteins contributes importantly to the control
of renal solutes and water transport along the entire
nephron. However, the underlying molecular mechanisms
that control and mediate the intracellular protein transport
are only incompletely understood.
Intracellular protein trafficking involves budding of
membrane protein bearing vesicles from a donor compart-
ment, their intracellular transport along the cytoskeleton and
finally the docking and fusion with the membrane of an
acceptor compartment. Rab proteins, members of the family
of small GTPases, control many of these events by switching
from an inactive (GDP-bound) to an active (GTP-bound)
conformation (Stenmark and Olkkonen 2001). Guanine
nucleotide exchange factors (GEF) activate Rab proteins and
thereby promote their binding to the cytoplasmic face of the
membrane of organelles, vesicles and the plasma membrane,
whereas GTPase activating proteins (GAP) terminate Rab
protein activity by stimulation of Rab protein-dependent GTP
hydrolysis (Barr and Lambright 2010; Frasa et al. 2012). One
of these Rab-GAP proteins is TBC1D4 that belongs to the
family of TBC (Tre-2/Bub2/Cdc16) domain-containing pro-
teins (Frasa et al. 2012), which were previously implicated in
the regulation of cell growth and differentiation (White et al.
2000). Numerous recent studies established TBC1D4 as an
important player in the insulin-dependent regulation of glu-
cose uptake in adipocytes and skeletal muscle cells. TBC1D4
is a protein of 160 kDa that becomes rapidly phosphorylated
by PKB/Akt in response to insulin stimulation. Therefore,
TBC1D4 is also referred to as Akt substrate of 160 kDa
(AS160) (Sano et al. 2003). In adipocytes and skeletal muscle
cells, TBC1D4 (AS160) is thought to retain the insulin-
dependent glucose transporter GLUT4 in an intracellular
storage compartment by deactivation of Rab proteins impor-
tant for GLUT4 cell surface targeting. Insulin-induced phos-
phorylation by PKB/Akt allows binding of 14-3-3 proteins,
which inactivates TBC1D4 and releases GLUT4 from intra-
cellular retention and hence increases GLUT4 cell surface
abundance (Eguez et al. 2005; Kane et al. 2002; Larance et al.
2005; Miinea et al. 2005; Sano et al. 2003). Interestingly,
TBC1D4 is expressed not only in fat and skeletal muscle, but
also in many other organs including the kidney (Kane et al.
2002; Nagase et al. 1998). Recent in vitro studies indicated
that TBC1D4 may participate in the regulation of ENaC
(Liang et al. 2010), Na?-K?-ATPase (Alves et al. 2010) and
AQP-2 (Jung and Kwon 2010; Kim et al. 2011) in renal epi-
thelia. However, although expression of TBC1D4 mRNA in
the kidney has been reported (Kane et al. 2002; Nagase et al.
1998), the precise cellular and subcellular localization of
TBC1D4 in the kidney in vivo has not yet been studied.
However, knowledge about the intrarenal distribution of
TBC1D4 is important to better understand its potential
physiological role in the kidney. Therefore, the aim of the
present study is to provide a detailed immunolocalization of
TBC1D4 along the mouse nephron using a novel TBC1D4
antibody together with a variety of antibodies against well-
established marker molecules, which allows unequivocal
identification of nephron segments.
Materials and methods
Animals
Animal studies were conducted in accordance with the
Swiss animal welfare regulations and after written consent
of the veterinarian office of the Canton of Zurich, Swit-
zerland. C57/Bl6 mice were obtained from Harlan (Horst,
The Netherlands). The TBC1D4-deficient mice (B6129S5-
Tbc1d4tm1Lex) had been generated by targeted deletion of
part of exon 1 of the TBC1D4 gene. To the best of our
knowledge, data on these mice have not yet been pub-
lished. However, details on the targeting strategy are
available via the website of Taconic (Hudson, NY, USA)
at http://www.taconic.com. For our experiments, the
TBC1D4-deficient mice were purchased from the Texas
Institute of Genomic Medicine (Houston, TX, USA). The
C56/Bl6 wildtype mice and the 129/SvEv-C57BL/6
TBC1D4-deficient mice were then crossed to a mixed
129/SvEv-C57BL/6 mouse background. Two sets of mice
with each three wildtype and three TBC1D4-deficient adult
male were used either for immunoblotting or for immu-
nohistochemistry. Mice had free access to standard lab
chow and tap water. TBC1D4-deficient mice appeared
healthy and did not reveal any gross abnormalities when
compared to the wildtype littermates.
Generation of anti-TBC1D4 antibody
The anti-TBC1D4 antibody was generated by immunizing
rabbits with a synthetic peptide corresponding to the
C-terminal amino-acid sequence of mouse TBC1D4
(CPTNDKAKAGNKP). The obtained antisera were sub-
sequently affinity purified against the peptide using stan-
dard procedures. Peptide synthesis, immunization of rabbits
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and antibody purification were custom made (Pineda Ab-
Service, Berlin, Germany).
Western blot
Total kidney homogenates were prepared as described
(Busque and Wagner 2009). Protein concentrations in the
tissue homogenates were assessed by a Bradford assay.
After denaturation of the proteins (5 min, 95 C) with
Laemmli loading buffer (supplemented with b-mercap-
toethanol, 500 mM), 25 lg of total protein lysates was
separated by SDS-PAGE and electrophoretically trans-
ferred to nitrocellulose membranes (Whatman Protran,
Millipore). After transfer, membranes were incubated in
LI-COR (LI-COR Biosciences, Bad Homburg, Germany)
membrane blocking buffer (30 min, rolling shaker, RT)
and incubated with primary antibodies overnight at 4 C.
Binding of the primary antibody was visualized using Infra
red dye-conjugated secondary IgG (LI-COR) and an
Odyssey infrared-scanner detection system (LI-COR).
Fixation and tissue processing
The kidneys of anesthetized mice were fixed by intravascular
perfusion of 3 % paraformaldehyde as described in detail
previously (Loffing et al. 2001). Kidneys were removed, cut
into coronal tissue slices of 2- to 3-mm thickness, mounted
on small cork disks, frozen in liquid propane and then stored
at -80 C until use (Loffing et al. 2001).
Immunohistochemistry
Serial sections (3–5 lm thick) of the kidneys were cut in a
cryostat, placed on chrome-alum gelatin-coated glass-
slides, thawed and stored in PBS until use and then pre-
treated for 10 min with 10 % normal goat serum in PBS.
Thereafter, the sections were incubated overnight in a
humidified chamber at 4 C with the primary antibodies
(Table 1), diluted in PBS-0.5 % bovine serum albumin.
Immunostaining of the serial sections with the primary
antibody occurred in the following order: (1) Anti-NKCC2;
(2) anti-TBC1D4 (AS160); (3) anti-NCC; (4) anti-TBC1D4
(AS160); (5) anti-cENaC; (6) anti-TBC1D4 (AS160); (7)
anti-AQP2. In addition to these polyclonal rabbit antibod-
ies, each kidney section was also stained with a mouse
monoclonal antibody against calbindin D28k. This sequen-
tial staining protocol allowed us to evaluate the distribution
of TBC1D4 in a given renal tubule along several consec-
utive sections. For unequivocal identification of proximal
tubules, some sections were co-stained with FITC-conju-
gated phalloidin (dilution 1:50, Molecular probes Inc.) that
strongly binds to the f-actin cytoskeleton of the proximal
tubule brush border. For identification of intercalated cells,
separate sections were co-stained with mouse monoclonal
antibodies against the bovine H?-ATPase (dilution 1:4). To
detect the binding sites of the primary antibodies, the
sections were incubated in a humidified chamber at room
temperature during 1 h with the following secondary
antibodies: Cy3-conjugated goat anti-rabbit IgG (Jackson
Immuno Research Laboratories, West Grove, PA, USA)
and FITC-conjugated goat anti-mouse IgG (Jackson
Immuno Research Laboratories). 4,6-diamidino-2-pheny-
lindol (DAPI, 1:1000; Sigma-Aldrich, Steinheim) was
added to the working dilution of the secondary antibodies
for nuclear staining. The coverslips were mounted using
DAKO-Glycergel (DakoCytomation, Denmark), to which
2.5 % 1,4-diazabicyclo(2,2,2)octane (DABCO; Sigma,
Steinheim) was added as fading retardant. Slides were
examined and images were captured with the 59 and 409
objectives of a fluorescence microscope (Leica DM6000
B). Images were acquired with a charge-coupled device
camera and processed by Adobe Photoshop CS3 and
Microsoft PowerPoint software. In separate experiments,
we also tested different antigen retrieval techniques
including microwave heating (Werner et al. 1996) and
SDS-pretreatment (Brown et al. 1996). These antigen
retrieval techniques did not improve the immunostainings
and did not reveal TBC1D4 in other cell types than under
standard conditions.
Segment definitions
We used the established distribution pattern of certain
marker proteins to define the specific segments of the
Table 1 Primary antibodies
used for immunohistochemistry
NKCC2 Na?-K?-2Cl-
cotransporter, NCC Na?-Cl-
cotransporter, ENaC amiloride-
sensitive epithelial Na?
channel, AQP2 aquaporin 2,
H?-ATPase vacuolar proton
ATPase, CB28 calbindin D28K
Antibody Host Dilution Description
Anti-TBC1D4 Rabbit 1:5,000 This study
Anti-NKCC2 Rabbit 1:40,000 Wagner et al. (2008)
Anti-NCC Rabbit 1:2,000 Loffing et al. (2004)
Anti-cENaC Rabbit 1:20,000 Wagner et al. (2008)
Anti-AQP2 Rabbit 1:20,000 Wagner et al. (2008)
Anti-H?-ATPase Mouse 1:4 Hemken et al. (1992)
Anti-CB28 Mouse 1:20,000 Swant, Bellinzona, CH
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mouse nephron. A well-developed brush border is indica-
tive for the proximal tubule. The expression of NKCC2 is
the hallmark of the thick ascending limb (TAL) and the
presence of NCC characterizes the distal convoluted tubule
(DCT), which can be subdivided into an early ENaC-neg-
ative portion (DCT1) and a late ENaC-positive portion
(DCT2) (Loffing et al. 2000; Schmitt et al. 1999). The CNT
and cortical CD (CCD) are NCC-negative, but ENaC- and
AQP2 positive (Kishore et al. 1996; Loffing and Kaissling
2003). CNT and CCD can be distinguished based on their
different histotopographical localization in the cortical
labyrinth and medullary ray, respectively (Reilly and
Ellison 2000). The two main subtypes of intercalated cells
were defined with the aid of an antibody against the vac-
uolar H?-ATPase, which is found in type A and type B
intercalated cells preferentially at the apical and basolateral
plasma membrane, respectively (Kim et al. 1999).
Results
Characterization of the TBC1D4 antibody
The affinity-purified anti-TBC1D4 antibody (Pineda) was
characterized by western blot and immunohistochemistry,
using TBC1D4 wildtype and knockout mice. The immu-
noblot showed a strong band of the expected size at
160 kDa and several weaker bands at lower molecular
weights. With the exception of one band at about 100 kDa,
the bands did not appear in kidney preparations from
TBC1D4-deficient mice indicating that they represent
TBC1D4 (Fig. 1a). The nature of the low molecular weight
forms of TBC1D4 is unclear and may represent splice
variants. Alternative splicing of the TBC1D4 gene has been
described (Baus et al. 2008). Likewise, the ENSEMBL
database (http://www.ensembl.org) lists seven different
TBC1D4 transcripts. Six of these transcripts are thought to
be protein coding. Four encompass the C-terminal peptide
sequence against which our TBC1D4 antibody is directed.
The other two variants are likely not detected by our
antibody. In immunohistochemical studies (Fig. 1c, d), our
TBC1D4 antibody showed a strong immunofluorescent
signal in several tubules in the renal cortex and renal
medulla. The staining was completely absent from kidneys
of TBC1D4-deficient mice further confirming that the
antibody specifically recognizes TBC1D4 in both immu-
noblotting and immunohistochemical studies (Fig. 1).
Distribution of TBC1D4 in the kidney
Overviews on the mouse renal cortex (Fig. 2) reveal that
TBC1D4 is expressed in NKCC2- and NCC-positive renal
tubules, in a few NKCC2- and NCC-negative tubules and
around the renal glomeruli. The majority of renal tubules,
which represent proximal tubules, is TBC1D4-negative.
At high magnification, it becomes evident that in the
renal corpuscle, TBC1D4 is highly abundant only in the
cytoplasm of the parietal epithelial cell of Bowman’s
capsule, while the other glomerular cell types (i.e. podo-
cytes, mesangial cells and endothelial cells) appear to be
TBC1D4-negative. The proximal tubule, which can be
easily discerned by its f-actin-rich brush border, is also
TBC1D4-negative (Fig. 3a, b). Only the very first proximal
tubule cells, directly adjacent to the Bowman’s capsule,
show occasionally some TBC1D4-immunoreactivity. The
rest of the proximal tubule as well as the entire straight
proximal tubule does not show any TBC1D4 immunore-
activity (Fig. 3a, c). In contrast, TBC1D4 is highly abun-
dant along the entire thin limbs, which is already strong in
the cytoplasm of the first descending thin limb (DTL) cells
(Fig. 3c, d) and remains intense until the end of the
ascending thin limb (ATL) up to the transition to the
NKCC2-positive thick ascending limb (TAL) (Fig. 3e, f).
In contrast to the strongly stained DTL cells, the first
TAL cells show only a very weak, if any TBC1D4
immunostaining (Fig. 3e). However, the TBC1D4-related
immunofluorescent signal increases along the axis of the
TBC1D4 TBC1D4
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Fig. 1 Characterization of affinity-purified rabbit anti-TBC1D4
antibodies by immunoblotting (a, b) and immunohistochemistry (c,
d). a In tissue homogenates of wildtype (?/?) mice, the anti-
TBC1D4 antibody detects a strong band of the expected size of
160 kDa (arrowhead) and several additional bands at lower molecular
weights. With the exception of one band at about 100 kDa, all bands
are absent in kidney homogenates of TBC1D4-deficient mice (-/-).
b Detection of b-tubulin (1:4,000) served to confirm equal protein
loading. c In immunohistochemistry, TBC1D4 is clearly abundant in
tubules of the renal cortex and the inner stripe of the renal outer
medulla of wildtype (?/?) mice. d Kidneys of TBC1D4-deficient
mice (-/-) are unstained. The border between the renal cortex and
the outer medulla is indicated by a dashed line. Scale bar *200 lm
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TAL in tubular flow direction (Fig. 4a). Consistently,
TBC1D4 immunostaining is usually more pronounced in
the cortical (Fig. 4b, c) than in the medullary TAL
(Fig. 4d, e). In the cortical TAL, the macula densa cells
show the strongest TBC1D4 immunostaining and can be
thus easily distinguished from the weaker stained sur-
rounding TAL cells (Fig. 4f, g).
The transition from the TAL to the distal convoluted
tubule (DCT) is characterized by a sharp increase in the
epithelial height and by an abrupt replacement of the TAL-
specific NKCC2 by the DCT-specific NCC. Consistent
with the clear demarcation between TAL and DCT,
TBC1D4 immunoreactivity rises abruptly from the last
TAL to the first DCT cell (Fig. 5 a–c). TBC1D4 protein
abundance remains high along the entire early DCT
(DCT1), but starts to decrease in the end portion of the
DCT (DCT2) and even further along the CNT. Co-immu-
nostainings with calbindin D28K (CB28) eased unequivocal
identification of DCT1, DCT2 and CNT based on the
different CB-staining intensities and prevalence of
CB28-negative intercalated cells in the three segments
(Fig. 5 d–h). Interestingly, along DCT2 and CNT, apical
cENaC localization and TBC1D4 abundance decrease in
parallel (Fig. 6a, b). TBC1D4 remains detectable along the
CNT, CCD and the outer medullary collecting duct
(OMCD) of the outer stripe, but is barely detectable in
the OMCD of the inner stripe (Fig. 6 c–q). Interestingly,
in CNT and CD, both the ENaC- and AQP2-positive
segment-specific cells as well as the ENaC- and AQP-2
negative intercalated cells reveal TBC1D4. Double
immunostainings with antibodies against TBC1D4 and
H?-ATPase show that all subtypes of intercalated cells
express TBC1D4 (Fig. 6 i–m). However, staining intensi-
ties in the cell types vary along the collecting system. In the
CNT, intercalated and the segment-specific CNT cells
express similar high levels of TBC1D4. However, along
the cortical collecting duct, TBC1D4 immunostaining
decreases in principal cells and in type A intercalated cells
and remains high in type B intercalated cells only. Along
the medullary collecting duct, TBC1D4 immunostaining
disappears in all cell types (Fig. 6 n–q).
Discussion
Our study provides a comprehensive analysis of the
localization and abundance of TBC1D4 along the mouse
nephron. Using a variety of nephron markers, we show that
TBC1D4 is expressed in the cytoplasm of epithelial cells
lining the parietal layer of Bowman’s capsule, the thin
limbs, the TAL, the DCT, the CNT and the CCD. More-
over, our study reveals marked differences in TBC1D4
protein abundance between cell types and along the axis of
the nephron, which point to a differential role of TBC1D4
NCCTBC1D4 NKCC2Cortex
G G G
OS
Fig. 2 Localization of TBC1D4 in the renal cortex and the outer
stripe (OS) of the outer medulla of mouse kidneys. Consecutive
cryosections immunostained with polyclonal antibodies against
TBC1D4, NKCC2, and NCC. TBC1D4 is present in cortical distal
tubules that are either NKCC2-positive (closed arrows), NCC-
positive (closed arrowheads), or NKCC2/NCC-negative. The latter
are located in the cortical labyrinth (open arrowheads) and in
medullary rays (open arrows). Moreover, glomeruli (G) are sur-
rounded by a rim of TBC1D4 immunoreactivity. Note the different
TBC1D4-staining intensities between NKCC2-positive TALs, NCC-
positive DCTs, and the NKCC2/NCC-negative CNTs and CCDs. The
dashed lines indicate the border between the renal cortex and the
outer stripe (OS) of the outer medulla. Scale bar *200 lm
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function along the renal tubule. Our findings are depicted
schematically in Fig. 7.
Previous studies reported TBC1D4 mRNA expression in
several organs including brain, heart, pancreas and the
kidney (Kane et al. 2002; Nagase et al. 1998). Now, we
show by immunoblotting and immunohistochemistry that
TBC1D4 is highly abundant also at the protein level in the
mouse kidney. With the exception of the proximal tubule,
TBC1D4 protein is found along the entire nephron with the
highest expression levels in Bowman’s capsule, thin limbs
and distal convoluted tubules. In most cells, TBC1D4
shows a diffuse intracellular localization, which corre-
sponds to the subcellular localization of TBC1D4 in cells
in vitro as reported previously (Alves et al. 2010). The
limited optical resolution of light microscopy does not
allow us to assign the intracellular staining pattern to
specific cell organelles, but the predominant diffuse intra-
cellular localization supports the idea that TBC1D4 is a
cytosolic Rab-GAP protein that controls membrane traf-
ficking at different intracellular sites. In fact, previous in
vitro studies suggested that TBC1D4 has Rab-GAP activity
towards Rab proteins 2a, 8a, 10, and 14 (Ishikura et al.
2007; Miinea et al. 2005; Sano et al. 2008), which are
known to regulate protein trafficking at many organelles
including the endoplasmic reticulum (ER), the Golgi
apparatus, sorting endosomes, and the plasma membrane
(Takai et al. 2001). Moreover, certain Rab proteins (e.g.
Rab8, 10, 11, 23) have been implicated in ciliary traffick-
ing and ciliopathies in various cell types including renal
epithelia (Lim et al. 2011). The Rab proteins targeted by
TBC1D4 in the kidney in vivo are unknown, but several
Rab proteins, including the ones listed above, are expressed
along the renal tubular system (Chabardes-Garonne et al.
2003; Pradervand et al. 2010).
TBC1D4 was initially identified as an insulin-regulated
protein that controls the intracellular trafficking of the
glucose transporter GLUT4 in adipocytes and skeletal
muscle cells (Kane et al. 2002; Sano et al. 2003). In the
kidney, epithelial glucose transport is thought to occur
mainly in the proximal tubule to recover filtered glucose
from the urine via the apical sodium-dependent glucose
transporter SGLT2 (Mather and Pollock 2011). However,
there is also evidence for GLUT4-mediated renal glucose
TBC1D4
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Fig. 3 Distribution of TBC1D4 in glomeruli and thin limbs. a–d
Cryosections stained with a polyclonal antibody against TBC1D4 and
phalloidin-FITC for detection of f-actin. a, b TBC1D4 is highly
abundant in the cytoplasm of the parietal epithelial cells (arrow) of
the glomerulus (G), but is undetectable in proximal convoluted
tubules (PCT), which are well discernible from other tubules by their
f-actin rich brush border. c, d TBC1D4 is undetectable in the f-actin-
rich proximal straight tubule (PST). The sharp morphological
transition from PST to the thin descending limbs (DTL) coincides
with a strong onset of TBC1D4 immunoreactivity in the epithelial
cells of the DTL. e, f Consecutive cryosections immunostained for
TBC1D4 and NKCC2. The strong TBC1D4-immunoreactivity in the
thin limb ceases abruptly at the well-discernible transition from the
ascending thin limb (arrow) to the NKCC2-positive medullary thick
ascending limb (TAL). Scale bars *30 lm
b
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uptake. GLUT4 was reported to be expressed in renal
vessels (Brosius et al. 1992), the glomerular tuft, the thick
ascending limb (Chin et al. 1993), and other distal tubules
(Albiston et al. 2011). The functional role of GLUT4 at
these sites is unclear, but it may facilitate basolateral glu-
cose uptake to fuel glycolytic ATP synthesis in cells with
high transport activities. Among the renal tubules, the
distal tubules have the highest density of mitochondria and
of the Na?-K?-ATPase (Kriz and Kaissling 2008), they are
rich in glycolytic enzymes such as hexokinase, pyruvate
kinase and phosphofructokinase (Guder and Ross 1984),
and they oxidize glucose at significant rates (Ross et al.
1986). The distal tubules do also express all components of
the classical insulin-dependent signal transduction path-
way, including the insulin receptor (Butlen et al. 1988) and
PKB/Akt (Chabardes-Garonne et al. 2003; Pradervand
et al. 2010). Therefore, it is conceivable that TBC1D4 may
contribute to an insulin-dependent GLUT4 regulation in
the kidney as it does in adipocytes and skeletal muscle
cells.
Aside from the well-established TBC1D4 target
GLUT4, recent studies suggested that TBC1D4 may also
regulate the trafficking and function of renal ion and water
transporting proteins. Alves et al. (2010) showed in renal
COS and Madin-Darby canine kidney (MDCK) cells that
TBC1D4 directly interacts with the a-subunit of the Na?-
K?-ATPase, which is known to drive sodium transport
across the basolateral plasma membrane of virtually all
renal tubular epithelial cells. In addition, two recent studies
provided evidence that TBC1D4 controls the cell surface
abundance of the vasopressin-dependent water channel
AQP2 (Jung and Kwon 2010; Kim et al. 2011) and the
aldosterone-dependent sodium channel ENaC (Liang et al.
2010). The studies indicated that TBC1D4 may retain these
proteins at intracellular sites until TBC1D4 becomes
phosphorylated by serine/threonine kinases including the
insulin-dependent PKB/Akt, adenosine monophosphate-
stimulated protein kinase (AMPK), the vasopressin-depen-
dent protein kinase A (PKA) and the aldosterone-dependent
serum and glucocorticoid induced kinase (SGK1) (Alves
et al. 2010; Comellas et al. 2010; Jung and Kwon 2010;
Kim et al. 2011; Liang et al. 2010). However, these stud-
ies were performed on cell lines in vitro. The current
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Fig. 4 TBC1D4 abundance along the thick ascending limb (TAL).
a TAL hit at the transition from the inner to the outer stripe. The
asterisk marks the abrupt change from the TBC1D4-negative PST to
the TBC1D4-positive DTL and hence indicates the border between the
outer stripe (OS) and the inner stripe (IS). The increase of TBC1D4
abundance in tubular flow direction (arrows) of the TAL is even more
pronounced when the staining intensities in cortical (b, c) and
medullary (d, e) TAL are compared. (b–e) Consecutive cryosections
immunostained with polyclonal antibodies against TBC1D4 and
NKCC2. TBC1D4 is well detectable in the cytoplasm of the
NKCC2-positive cortical TAL (b, c), but barely detectable in the
NKCC2-positive medullary TAL (d, e). f–i Cryosections co-stained
with a polyclonal antibody against TBC1D4 and with DAPI for
detection of nuclear DNA. The macula densa is well recognizable by
the closely packed DAPI-positive cell nuclei (arrowheads) directly
adjacent to the mesangium (hash symbol) of the glomerulus. TBC1D4
abundance is more pronounced in the macula densa cells than in the
surrounding TAL cells. Arrow strong TBC1D4-positive parietal
epithelial cells of Bowman’s capsule. Scale bars *30 lm
b
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Fig. 5 Distribution of TBC1D4
along TAL, distal convoluted
tubule (DCT) and connecting
tubule (CNT). a–h Consecutive
cryosections immunostained
with antibodies against
TBC1D4, NKCC2, NCC and
CB28. a–c The sharp transition
from the NKCC2-positive TAL
to the NCC-positive DCT
(arrowheads) coincides with an
increase in the cytoplasmic
TBC1D4 abundance in the
epithelial cells. (d–f) TBC1D4
cytoplasmic protein abundance
remains high in the early DCT
(DCT1), but starts to decrease at
the transition to the late DCT
(DCT2). The abrupt change
from high to very high
abundance of CB D28 and the
first appearance of CB28-
negative intercalated cells
(arrow) mark the transition
from DCT1 to DCT2. (g, h) The
axial decrease of TBC1D4-
immunoreactivity is visible
along the transition from DCT1
(intermediate CB28 staining, no
intercalated cells), to DCT2
(strong CB28 staining, few
CB28-negative intercalated
cells), and finally to the CNT
(intermediate CB28, many
CB28 negative intercalated
cells). Note the TBC1D4
immunoreactivity in both
segment-specific and
intercalated cells. Scale bars
*30 lm
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Fig. 6 Distribution of TBC1D4 in DCT, CNT, cortical collecting
duct (CCD), and outer medullary collecting duct (OMCD). a, b
Consecutive cryosections immunostained with antibodies against
TBC1D4 and cENaC. TBC1D4 is highly abundant in the cENaC-
negative early DCT (DCT1) and the cENaC-positive late DCT
(DCT2), but is less abundant in the CNT. Note the predominant apical
localization of cENaC in DCT2 and the pronounced intracellular
localization of ENaC in CNT, which is similar to previous reports
(Loffing et al. 2000). Consecutive cryosections of CNT (c–e) and
CCD (f–h) immunostained for TBC1D4, cENaC, and AQP2.
TBC1D4 is abundant in CNT and CCD. Note that TBC1D4 is found
in both the ENaC- and AQP2-positive segment-specific cells and the
ENaC- and AQP2-negative intercalated cells. The higher levels of
AQP2 expression discern the CCD from the CNT. Double
immunostainings in CNT (i, j) and CCD (k, l) for TBC1D4 and
H?-ATPase confirm that TBC1D4 is abundant not only in the
segment-specific CNT and CCD cells (open arrowheads), but also in
type A (arrow) and type B (closed arrowhead) intercalated cells, with
predominant apical and basolateral H?-ATPase localization, respec-
tively. However, in the collecting duct, TBC1D4 abundance is rather
low in the segment-specific and type A intercalated cells, while it
remains high in the type B intercalated cells. m–p Consecutive
cryosections of outer medullary collecting ducts for TBC1D4 and
AQP2. In the outer stripe of the outer medulla, the collecting duct
(OMCDos) shows very weak TBC1D4 immunostaining. In the
collecting duct of the inner stripe (OMCDis), TBC1D4 is barely
detectable and vanishes. Scale bars *30 lm
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demonstration that TBC1D4 is highly abundant in the
distal nephron and the collecting duct supports the idea that
TBC1D4 controls the trafficking and function of the Na?-
K?-ATPase, ENaC and AQP2 not only in vitro but also in
the kidney in vivo.
Interestingly, the abundance of TBC1D4 changes along
the distal tubule. While the abundance of TBC1D4 is rather
low in the medullary TAL, it increases along the cortical
TAL to reach very high levels in the early DCT, before it
starts to decrease again from the late DCT over the CNT to
the CCD. The reasons for these axial differences are
unclear, but they point to a differential regulation of
TBC1D4 along the nephron, which might be relevant for
the cell surface targeting of TBC1D4-regulated proteins.
Notably, axial differences in the abundance and/or activity
were described for the Na?-K?-ATPase, ENaC, and AQP2
(reviewed in (Loffing and Kaissling 2003). Although pre-
vious studies from others (Liang et al. 2010) and our lab-
oratory indicated that aldosterone controls the expression
of TBC1D4, it is unlikely that axial differences in the
response to aldosterone explain the axial gradient of
TBC1D4 along the distal tubule. In fact, aldosterone-
binding, expression of the mineralocorticoid receptor and
the transcriptional response to aldosterone appear to be
rather homogenous along the CNT and CCD (Loffing and
Korbmacher 2009).
TBC1D4 is also highly abundant in the thin limbs and
parietal epithelial cells (PECs) of Bowman’s capsule. The
thin limbs play an important role for the urinary concen-
tration mechanism by the countercurrent multiplication
process. At least four different cells types were described,
which specifically form either the descending or ascending
limbs in short- and long-looped nephrons, respectively
(Kriz and Kaissling 2008). As we did not see any unstained
thin limb, we conclude that all subtypes of thin limb cells
express TBC1D4. The functional role of TBC1D4 in these
cells is unclear. The descending thin limbs express high
levels of the water channel AQP1 (Sabolic et al. 1992) and
the urea transporter UT-A2 (Wade et al. 2000) while the
ascending thin limbs express the chloride channel ClC-K1
(Uchida et al. 1995). To what extend these channels and
transporters are regulated by trafficking is unknown.
However, it is remarkable that the thin limbs do also
express high levels of the SNARE protein syntaxin 3,
which is known to be involved in regulation of vesicular
trafficking (Mandon et al. 1997). The PECs of Bowman’s
capsule form a rather thin squamous epithelium, which
likely has a more dynamic cell turnover and cell metabo-
lism as previously thought (Ohse et al. 2009). Consistent
with a high metabolic activity, PECs express the glucose
transporters GLUT4 and GLUT1 (Heilig et al. 1995),
which are both regulated by TBC1D4 (Mendes et al. 2010).
We just started to learn about the in vivo role of
TBC1D4 in the regulation of glucose homeostasis. Patients
with type-2 diabetes were shown to have reduced levels of
TBC1D4 phosphorylation in skeletal muscle cells, which
may contribute to reduced cell surface targeting of GLUT4
(Karlsson et al. 2005). Likewise, transgenic mice with
targeted inactivation of the phosphorylation site Thr649 in
TBC1D4 exhibit a reduced GLUT4 abundance and lowered
glucose uptake into skeletal muscle cells, leading to
reduced insulin-sensitivity and delayed glucose disposal
(Chen et al. 2011). Moreover, patients with a truncated
form of TBC1D4, due to a premature stop-codon in the
Fig. 7 Schematic
representation of distribution
and abundance of TBC1D4
along the mouse nephron and
collecting duct. The green bar
represents the distribution of
TBC1D4. The other bars
indicate the appearance or
cessation of the used marker
proteins. Shadings indicate
different levels of
immunostaining intensities. For
abbreviations, segment
definitions and further
explanations, see ‘‘Materials
and methods’’ and ‘‘Results’’
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TBC1D4 gene, show severe insulin-resistance with
hyperglycemia and acanthosis nigrans (Dash et al. 2009).
The renal phenotype of the mouse model and the patients
has not yet been studied. The detailed description of the
intrarenal distribution of TBC1D4 may now provide a basis
on which further studies could address the in vivo role of
TBC1D4 in the kidney.
Thus, TBC1D4 is expressed in the kidney in many cell
types in which it may contribute to the regulation of several
renal transport proteins including GLUT1, GLUT4, Na?-
K?-ATPase, ENaC, and AQP2. The fact that TBC1D4 is
not detectable in all renal cell types indicates that TBC1D4
is not a ubiquitous regulator of membrane trafficking, but
may have tissue- and cell type-specific functions. In the
kidney, TBC1D4 may control renal ion and water handling
and hence contribute to the control of extracellular fluid
homeostasis.
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